Can a safer heart rate drug save lives in septic shock?
NCT ID NCT04031573
First seen Apr 07, 2026 · Last updated Apr 25, 2026 · Updated 1 time
Summary
This study tests a drug called ivabradine to see if it can safely lower heart rate in adults with septic shock, a life-threatening infection that causes very fast heartbeats. Unlike standard drugs, ivabradine slows the heart without weakening its pumping strength or dropping blood pressure. The goal is to reduce strain on the heart and improve survival at 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henri Mondor Hospital
Créteil, 94000, France
Conditions
Explore the condition pages connected to this study.